First, it started in Australia. Now it's coming to the U.S. and guess who is funding the Vaxxas vaccine patch? "The HHS Biomedical Advanced Research and Development Authority has awarded Vaxxas $22 million to conduct phase 1 studies of its COVID-19 vaccine patch. The phase 1 trials in the U.S. and Australia will evaluate the ability of the company’s high-density micro-array patch (HD-MAP) to deliver both adjuvanted and unadjuvanted COVID-19 vaccines to more than 400 participants. The patch has “shown the potential to transform vaccine delivery with lower dose requirements, enabling more patient-doses to be manufactured more quickly from limited vaccine supply,” the company said."
7Upvotes
1Remind

More from The Conscious Resistance

Full interview will be released as part of The Pyramid of Power docu-series featuring Mark Passio, G. Edward Griffin, James Corbett, Ryan Christian, and more!

269 views ·

More from The Conscious Resistance

Full interview will be released as part of The Pyramid of Power docu-series featuring Mark Passio, G. Edward Griffin, James Corbett, Ryan Christian, and more!

269 views ·